3 Stocks Hitting High Notes

Hitting fresh highs can either signal that a stock is on its way to greatness, or that it has run its course. Even with the risk of the latter, searching for these outperformers can reveal companies that are doing something right, much to their investors' delight.

I'm a poet and didn't know it
With that in mind, we'll use the aggregate intelligence of the 110,000-plus investors participating in Motley Fool CAPS to find stocks hitting 52-week highs today. If our community favors a stock with a four- or five-star rating, Fools may want to give those companies a closer look.

Here are three such stocks:

 Company

Today's High

Industry

CAPS Rating (5 max)

Fools Saying Outperform

More Info

EZCORP (Nasdaq: EZPW)

$15.15

Financial Services

****

258 of 275

Research

Exactech (Nasdaq: EXAC)

$29.99

Health Services

*****

116 of 121

Research

Radyne (Nasdaq: RADN)

$11.48

Telecommunications

****

184 of 196

Research

Source: Motley Fool CAPS, as of July 8, 2008.

Other five-star health services companies

  • Quest Diagnostics (NYSE: DGX): Stock price is 13.4% cheaper than a year ago.
  • Laboratory Corp. of America (NYSE: LH): Stock price is 16.8% cheaper than a year ago.

Other five-star telecommunications companies

  • Millicom International Cellular (Nasdaq: MICC): Stock price is 2.1% cheaper than a year ago.
  • Corning (NYSE: GLW): Stock price is 13.9% cheaper than a year ago.

Come and join us on CAPS to learn more about these and countless other interesting stock ideas.

Want to make money in up, down, and rollercoaster markets? Find out how. Claim your private invitation to a breakthrough new service from Motley Fool Co-founder David Gardner and team. Simply enter your email below.

Dan Dzombak does not have a financial position in any of the stocks mentioned in this article. LabCorp is a recommendation of Stock Advisor. Quest Diagnostics is an Inside Value pick. The Motley Fool has a disclosure policy.

Comment (1)
Recommended (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • On July 11, 2008, at 11:48 AM, sandyclaws99 wrote: Report this Comment

    Great research on RADN!

    Anyone who wants to buy should hurry, because the tender offer from CMTL for $11.50 expires 7/15.

    Seriously, touting RADN at $11.48 with an active tender offier of $11.50 is hardly up to Motley Fool standards.

Add your comment.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 680398, ~/articles/articlehandler.aspx, 10/15/2008 4:22:43 PM,

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Related Tickers

Quest Diagnostics, Inc.

DGX Down! $40.85 -4.17 (-9.26%) 4:00 PM
CAPS Rating:
454 Outperforms
22 Underperforms
Rate This Stock

Major Indices

S&P 500907.70 -9.05%
DJIA8,577.91 -7.87%
NASD1,628.33 -8.47%
Updated: 4:04:23 PM
Sponsored by:

The Motley Poll

What do you think will be the best performing sector over the next six months?

Sponsored by: